| Followers | 2421 |
| Posts | 92347 |
| Boards Moderated | 1 |
| Alias Born | 09/12/2003 |
Tuesday, January 26, 2021 5:10:33 AM
USA TODAY: Revive Therapeutics in Phase 3 clinical trial for COVID-19 treatment
https://www.usatoday.com/story/sponsor-story/imperium-group/2021/01/25/revive-therapeutics-phase-3-clinical-trial-covid-19-treatment/6672439002/
https://www.usatoday.com/story/sponsor-story/imperium-group/2021/01/25/revive-therapeutics-phase-3-clinical-trial-covid-19-treatment/6672439002/
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM

